Cardlytics, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

4 Mar 2026

CDLX

10-K: Cardlytics: Strategic Shift, EBITDA Up, Revenue Down

Cardlytics reports improved Adjusted EBITDA and positive operating cash flow for 2025, despite revenue and billings decline, as Bridg is sold.

NASDAQ

12 Mar 2025

CDLX

Cardlytics, INC

10-K: Cardlytics Reports Annual Results: Revenue Declines Amid Strategic Shifts

Cardlytics' 2024 annual report reveals a decrease in revenue despite growth in monthly active users, highlighting challenges in monetizing its platform and managing costs.

NASDAQ

14 Mar 2024

CDLX

Cardlytics, INC

10-K: Cardlytics Amends Loan Agreement, Secures Consent for Asset Sale and Updates Financial Covenants

Cardlytics secures lender consent for the sale of HSP EPI assets, amends its loan agreement to increase borrowing capacity, and updates financial covenants.